Pfizer, the seventh largest pharmaceutical advertiser in the United States, announced they will be acquiring Allergan by the end of 2016. This will be the largest merger in the healthcare industry, where in total Pfizer and Allergan spent $1.6 billion on advertising in 2014.
Blog Category: Deals & Mergers
In a surprising move, Google is following Madison Avenues buying preference rather than blazing their own unique path as they’ve done historically. The company that popularized the auction based pricing model for advertising is changing its course when it comes to display advertising and video. Inking a deal, which by the sounds of it will […]
Quadrant pulls off a whopper of a deal and acquires Elsevier’s IMNG group for an undisclosed sum making the newly combined company, which will go under the name Frontline Medical Communications, the largest medical publisher by ad volume in the US. Kudos to Steve Stoneburn on executing and orchestrating a true David buys Goliath deal […]
Consolidation even within the conglomerates pushes Publicis’ Razorfish Health together with Healthware to form Razorfish | Healthware. This is great for pharma clients, as Healthware appears to give Razorfish a much greater International presence and local offices and expertise in several countries around the globe.
Congratulations to the team over at WorldOne on their acquisition of Sermo. Applying an established market research business against the well known but struggling physician community may be one of the best things that could happen to the online community. Terms of the deal or deal structure do not appear to have been disclosed. Sermo […]
The healthcare publisher deal space continues to heat up with Remedy Health Media acquiring HealthCentral. Cunnion in Schroeder out. Remedy Health Media Acquires HealthCentral – Kara Swisher – News – AllThingsD.
Maybe it’s Lipitor’s pending loss of patent protection and the drought in pharmaceutical pipelines, or more likely perhaps is the announcement of significant minority shareholder positions by both Carl Icahn and George Soros in recent weeks and the interesting phone calls with management that likely took place since)… Or perhaps is competition from Everyday Health, […]
Abbott announced that it will separate into two publicly traded companies, one its $18-billion pharma unit and the other its $22-billion diversified medical products business. The research-based pharmaceutical company, which has yet to be named, will be led by 30-year Abbott veteran Richard Gonzalez, currently EVP for global pharmaceuticals. It will focus on “select specialty […]
P&G ties up a sponsorship with BlogHer network featuring 10 P&G brands. Not every advertisers is fearful of UGC and community… some are embracing it’s power. MediaPost Publications P&G Ties Up One-Year Deal With BlogHer 08/08/2011. Here are some tips for Pharma on using social media (if you dare)
Publicis, having already rolled up early entrant digital agency brands such as Digitas and Razorfish, now continues on the buying spree and acquires Rosetta, one of the largest digital strategy agencies that had, up until now, remained independent. The all cash acquisition was for $575MM, represents a purchase price of 2.3X revenue and includes additional […]